ADIL Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 4.26%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $0.00

Adial Pharmaceuticals Insider Trading History Chart

Adial Pharmaceuticals Share Price & Price History

^$0.33

▲ +0.0111 (3.52%)

As of 12/4/2025 05:00 PM ET

Days: 30 | 90 | 365

Adial Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
9/29/2023	Kevin Schuyler	Director	Buy	700	$2.74	$1,918.00	700

SEC Filings (Institutional Ownership Changes) for Adial Pharmaceuticals (NASDAQ:ADIL)

16.41% of Adial Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Adial Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/17/2025	Citadel Advisors LLC	143,791	$51K	0.0%	N/A	0.599%
2/17/2025	Citadel Advisors LLC	54,508	$55K	0.0%	+63.8%	0.850%
2/13/2025	Renaissance Technologies LLC	47,613	$48K	0.0%	N/A	0.743%
2/12/2025	Geode Capital Management LLC	61,847	$62K	0.0%	+36.0%	0.965%
8/9/2024	Renaissance Technologies LLC	34,346	$39K	0.0%	-32.8%	0.811%
5/20/2024	Virtu Financial LLC	20,469	$27K	0.0%	N/A	0.484%
2/13/2024	Armistice Capital LLC	159,000	$0.30M	0.0%	N/A	9.578%
11/9/2023	Manchester Capital Management LLC	48,097	$0.13M	0.0%	-96.0%	3.942%
5/9/2023	Manchester Capital Management LLC	1,202,452	$0.42M	0.1%	N/A	4.216%
11/7/2022	Virtu Financial LLC	77,694	$27K	0.0%	+142.7%	0.301%
8/2/2022	Thompson Davis & CO. Inc.	21,000	$28K	0.0%	N/A	0.088%
7/22/2022	Truist Financial Corp	33,862	$45K	0.0%	N/A	0.142%
7/13/2022	Private Advisor Group LLC	21,400	$29K	0.0%	-37.3%	0.090%
11/12/2021	Oppenheimer & Co. Inc.	38,500	$0.17M	0.0%	+37.5%	0.190%
11/12/2021	NorthRock Partners LLC	10,000	$43K	0.0%	N/A	0.049%
10/29/2021	Commonwealth Equity Services LLC	36,461	$0.16M	0.0%	+25.5%	0.180%
8/16/2021	State Street Corp	48,954	$0.13M	0.0%	N/A	0.260%
8/13/2021	Northern Trust Corp	21,873	$56K	0.0%	N/A	0.116%

Data available starting January 2016

Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its lead product is AD04, a serotonin-3 antagonist, which is in Phase III clinical trial for the treatment of alcohol use disorder. The company also focuses on developing drug candidates for non-opioid pain reduction and other diseases and disorders. Adial Pharmaceuticals, Inc. was founded in 2010 and is based in Charlottesville, Virginia.

Today's Range

Now: $0.33

$0.30

$0.33

50 Day Range

MA: $0.35

$0.30

$0.42

52 Week Range

Now: $0.33

$0.22

$1.30

Volume

364,694 shs

Average Volume

336,757 shs

Market Capitalization

$7.83 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.11

Who are the major institutional investors of Adial Pharmaceuticals?: Adial Pharmaceuticals' top institutional shareholders include:
Citadel Advisors LLC — 0.60%
Learn More about top institutional investors of Adial Pharmaceuticals stock.
Which major investors are buying Adial Pharmaceuticals stock?: In the last quarter, ADIL stock was bought by institutional investors including:
Citadel Advisors LLC